1. Home
  2. ABEO vs TBRG Comparison

ABEO vs TBRG Comparison

Compare ABEO & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • TBRG
  • Stock Information
  • Founded
  • ABEO N/A
  • TBRG 1979
  • Country
  • ABEO United States
  • TBRG United States
  • Employees
  • ABEO N/A
  • TBRG 3219
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • TBRG
  • Sector
  • ABEO Health Care
  • TBRG
  • Exchange
  • ABEO Nasdaq
  • TBRG NYSE
  • Market Cap
  • ABEO 247.8M
  • TBRG 271.5M
  • IPO Year
  • ABEO 1980
  • TBRG N/A
  • Fundamental
  • Price
  • ABEO $5.70
  • TBRG $18.60
  • Analyst Decision
  • ABEO Strong Buy
  • TBRG Buy
  • Analyst Count
  • ABEO 3
  • TBRG 3
  • Target Price
  • ABEO $18.00
  • TBRG $14.67
  • AVG Volume (30 Days)
  • ABEO 229.2K
  • TBRG 66.0K
  • Earning Date
  • ABEO 11-14-2024
  • TBRG 11-07-2024
  • Dividend Yield
  • ABEO N/A
  • TBRG N/A
  • EPS Growth
  • ABEO N/A
  • TBRG N/A
  • EPS
  • ABEO N/A
  • TBRG N/A
  • Revenue
  • ABEO N/A
  • TBRG $337,674,000.00
  • Revenue This Year
  • ABEO N/A
  • TBRG $1.01
  • Revenue Next Year
  • ABEO $18,714.71
  • TBRG $6.05
  • P/E Ratio
  • ABEO N/A
  • TBRG N/A
  • Revenue Growth
  • ABEO 147.52
  • TBRG 0.26
  • 52 Week Low
  • ABEO $3.05
  • TBRG $7.55
  • 52 Week High
  • ABEO $9.01
  • TBRG $18.83
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 34.30
  • TBRG 63.03
  • Support Level
  • ABEO $5.45
  • TBRG $17.71
  • Resistance Level
  • ABEO $6.04
  • TBRG $18.47
  • Average True Range (ATR)
  • ABEO 0.19
  • TBRG 0.60
  • MACD
  • ABEO -0.04
  • TBRG -0.19
  • Stochastic Oscillator
  • ABEO 19.47
  • TBRG 35.32

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About TBRG TRUBRIDGE INC

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.

Share on Social Networks: